씨버스 글로벌(CBUS)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $1.61 (-1.23%), 시가총액 $0.11B, 52주 최저~최고 $1.16 ~ $4.05.
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
씨버스 글로벌의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
씨버스 글로벌의 현재 주가는 $1.61 (-1.23%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
씨버스 글로벌의 시가총액은 약 $0.11B입니다.
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals